Two Sigma Investments’s Monte Rosa Therapeutics GLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$317K Buy
19,300
+5,300
+38% +$101K ﹤0.01% 4039
2025
Q4
$220K Sell
14,000
-147,481
-91% -$1.99M ﹤0.01% 3731
2025
Q3
$1.2M Sell
161,481
-78,456
-33% -$416K ﹤0.01% 2461
2025
Q2
$1.08M Buy
239,937
+16,807
+8% +$75K ﹤0.01% 2200
2025
Q1
$1.04M Sell
223,130
-55,655
-20% -$341K ﹤0.01% 2157
2024
Q4
$1.93M Buy
278,785
+265,285
+1,965% +$1.99M ﹤0.01% 1744
2024
Q3
$71.5K Buy
+13,500
New +$68.1K ﹤0.01% 2933
2023
Q4
Sell
-66,750
Closed -$320K 3232
2023
Q3
$320K Buy
+66,750
New +$430K ﹤0.01% 2467
2023
Q2
Sell
-10,100
Closed -$78.7K 3104
2023
Q1
$78.7K Buy
+10,100
New +$70.2K ﹤0.01% 2703

Other funds holding GLUE